TingBo Liang
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor (NCT06478251) | TingBo Liang | 2024-02-01 |
Track TingBo Liang automatically
Every clearance here is in the API, with alerts when new ones post.